Popular GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight, but what should patients know about ...

to Wegovy, made by Novo Nordisk, people randomly assigned to receive Zepbound lost about 20% of their body weight after about 18 months, while those taking Wegovy lost nearly 14% of their body weight.

With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

compared with an average of 13.7% body weight loss (33.1 pounds) for those on Wegovy. Related Deep belly fat could predict Alzheimer's disease decades ahead of symptoms Gastric balloon being ...

Meanwhile, adults using Wegovy, the brand name for semaglutide, lost about 14 percent of their body weight on average during that same period, according to a release from Eli Lilly. That ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.

For the uninitiated, both Zepbound (tirzepatide) and Wegovy (semaglutide) are weight loss drugs. They target hormones that ...